Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | carbonic anhydrase II | 0.0146 | 1 | 1 |
Schistosoma mansoni | carbonic anhydrase-related | 0.0054 | 0.3258 | 0.3258 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.0146 | 1 | 1 |
Leishmania major | carbonic anhydrase-like protein | 0.0146 | 1 | 1 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0146 | 1 | 1 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0134 | 0.9115 | 0.8817 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0146 | 1 | 1 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.001 | 0 | 0.5 |
Schistosoma mansoni | SmCB2 peptidase (C01 family) | 0.0134 | 0.9115 | 0.9115 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.3258 | 0.3258 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.0054 | 0.3258 | 0.3258 |
Loa Loa (eye worm) | cathepsin B | 0.0044 | 0.2523 | 0.2523 |
Schistosoma mansoni | carbonic anhydrase-related | 0.0054 | 0.3258 | 0.3258 |
Toxoplasma gondii | hypothetical protein | 0.0054 | 0.3258 | 1 |
Brugia malayi | cathepsin B-like cysteine proteinase | 0.0134 | 0.9115 | 0.9115 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0054 | 0.3258 | 0.3258 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.3258 | 0.3258 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0044 | 0.2523 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.9115 | 0.9115 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.3258 | 0.3258 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0146 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.3258 | 0.3258 |
Echinococcus multilocularis | carbonic anhydrase II | 0.0146 | 1 | 1 |
Echinococcus multilocularis | cathepsin b | 0.0134 | 0.9115 | 0.9115 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0134 | 0.9115 | 0.9115 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.0146 | 1 | 1 |
Echinococcus granulosus | carbonic anhydrase | 0.0054 | 0.3258 | 0.3258 |
Echinococcus granulosus | carbonic anhydrase | 0.0054 | 0.3258 | 0.3258 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0146 | 1 | 1 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0054 | 0.3258 | 0.3258 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.0054 | 0.3258 | 0.3258 |
Echinococcus granulosus | cathepsin b | 0.0134 | 0.9115 | 0.9115 |
Onchocerca volvulus | Bile acid receptor homolog | 0.001 | 0 | 0.5 |
Echinococcus multilocularis | carbonic anhydrase | 0.0054 | 0.3258 | 0.3258 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0054 | 0.3258 | 0.3258 |
Plasmodium falciparum | carbonic anhydrase | 0.0054 | 0.3258 | 0.5 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0146 | 1 | 1 |
Giardia lamblia | Cathepsin B precursor | 0.0044 | 0.2523 | 0.5 |
Schistosoma mansoni | carbonic anhydrase-related | 0.0054 | 0.3258 | 0.3258 |
Echinococcus multilocularis | carbonic anhydrase | 0.0054 | 0.3258 | 0.3258 |
Echinococcus granulosus | carbonic anhydrase | 0.0054 | 0.3258 | 0.3258 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.001 | 0 | 0.5 |
Onchocerca volvulus | 0.001 | 0 | 0.5 | |
Echinococcus multilocularis | cathepsin b | 0.0134 | 0.9115 | 0.9115 |
Echinococcus granulosus | cathepsin b | 0.0134 | 0.9115 | 0.9115 |
Schistosoma mansoni | carbonic anhydrase | 0.0054 | 0.3258 | 0.3258 |
Giardia lamblia | Cathepsin B precursor | 0.0044 | 0.2523 | 0.5 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0054 | 0.3258 | 0.3258 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.0146 | 1 | 1 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0044 | 0.2523 | 0.2523 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0134 | 0.9115 | 0.9115 |
Giardia lamblia | Cathepsin B precursor | 0.0044 | 0.2523 | 0.5 |
Echinococcus multilocularis | carbonic anhydrase | 0.0054 | 0.3258 | 0.3258 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0134 | 0.9115 | 0.9115 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.5012 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.